News
The Swedish Cancer Society funds research at the Dept. of Immunotechnology
The Cancer Target research team headed by Prof. Sara Ek has been awarded 3 MSEK by the Swedish Cancer Society to carry out a project entitled "A cellular and molecular dissection of the lymphoma tumor immune microenvironment to understand and address treatment resistances".
Antibody specificity identified at the Dept. of Immunotechnology is heading towards clinical trials
Antibody AKIR001, the precursor of which was isolated at the SciLifeLab unit of the Dept. of Immunotechnology, in collaboration with Prof. Marika Nestor of Uppsala University, and other units of the SciLifeLab Drug Discovery and Development platform is heading for first-in-human clinical trials. For more information read additional information from [...]
Winner of pitch prize at Engineering Health retreat
Asger Meldgaard Frank of the Dept. of Immunotechnology wins the pitch price at the Faculty of Engineering's profile area Engineering Health 2024 retreat. Great start for the new Biomolecular and Cellular Technology focus area within the profile area.
Immunotechnology research on the cover of Blood Advances
The cancertarget group, led by Prof. Sara Ek, is applying joint strategies for image and spatial omic analysis to reveal novel insight on tumor and immune cell interactions. In the recent issue of Blood Advances, our paper was featured on the journal's cover. In the article, we describe how macrophage polarization impacts treatment response in [...]
Anna Sandström appointed as Associate Professor in Immunotechnology
Anna Sandström has been appointed as Associate Professor in Immunotechnology by the Faculty of Engineering at Lund University. Her research is focused on spatial biology of solid tumors. Currently, her group is working on profiling tumor microenvironments of ovarian cancer to understand susceptibility of targeted treatments including different [...]
Immunotechnology research in antibody engineering supported by grant
A team led by Prof. Mats Ohlin of the Dept. of Immunotechnology has received a grant of 3 MSEK from Mrs. Berta Kamprad's Foundation to further develop antibodies for cancer therapy using co-called chimeric antigen receptor (CAR) technology.
New tool for defining your antibody-encoding genes
The antibody team within the Dept. of Immunotechnology, together with an international team of the Adaptive Immune Receptor Repertoire (AIRR) Community, today published a study that allows you to, through use of an improved human immunoglobulin reference set, better define your antibody-encoding genes. This tools will allow you to properly detect [...]
Idéforum 2023
Since 2009, the LMK foundation is gathering around ten, promising young researchers across faculties at Lund University to an idea forum in Örum. Associate senior lecturer Anna Gerdtsson from the Department of Immunotechnology was selected to participate this year (22.-24.9.2023). The three-day meeting promotes exchange of experiences and ideas [...]
Kulturnatten 2023
Three representatives of the Department of Immunotechnology share their knowledge with general public during Kulturnatten 2023. Sarah Richtmann (on the picture), Tova Hermodsson and Jana Hagman tought both kids and adults how to pipette, all about immunotherapy and latest trends in cancer imaging.
Combination of high throughput technologies advances antibody development
The antibody development infrastructure U-READ at the Dept. of Immunotechnology, headed by Prof. Mats Ohlin, in collaboration with the Department of Laboratory Medicine, and BioInvent International AB, have demonstrated the utility of a combination of next generation sequencing and bioinformatics as a screening tool to isolate novel cell-bindning [...]